Navigation Links
Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
Date:8/20/2007

pprovals in developed markets and significant progress in New Drug Discovery Research. The Company's foray into Novel Drug Delivery Systems has led to proprietary "platform technologies", resulting in a number of products under development. The Company is serving its customers in over 125 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 49 countries and manufacturing operations in 11 countries.

*Vicodin(R) ES Tablets is a registered trademark of Abbott Laboratories

*Norco(R) Tablets is a registered trademark of Watson Pharmaceuticals Inc.

*Lortab(R) Tablets is a registered trademark of UCB Inc.

CONTACTS: Charles M. Caprariello

Vice President, Corporate Communications

Ranbaxy Inc.

(609) 720-5615

Edwige Buteau

RF Binder Partners Inc.

(212) 994-7517

edwige.buteau@rfbinder.com

Anuj Baveja

RF Binder Partners Inc.

(212) 994-7552

anuj.baveja@rfbinder.com


'/>"/>
SOURCE Ranbaxy Pharmaceuticals Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2

Related medicine technology :

1. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
2. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
3. DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan PDT to Treat Esophage al Dysplasia
4. Gloucester Pharmaceuticals Receives Fast Track Designation for Romidepsin in Peripheral T-Cell Lymphoma
5. Major Manufacturer of Unapproved and Adulterated Drugs
6. FDA Advises Manufacturers to Test Glycerin for Possible Contamination
7. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
8. New Report Looking at Chiral Technologies Analyzes the Global Market Growth Forecasts Driven By Two Very Important Components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals
9. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
10. Clinical Trial Excellence: Shaping Markets Through Early Communication of Clinical Trial Data
11. New Study Reveals Limitations of a Complex and Challenging Global Tuberculosis Drug Marketplace
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... MAQUET Cardiovascular LLC, a leading ... it has signed a three-year single source ... supply contracting company, for MAQUET,s market-leading VASOVIEW ... products assist healthcare providers in obtaining veins ... only small incisions. This allows for faster ...
(Date:12/16/2009)... Dec. 16 Naurex Inc., a new ... and other CNS disorders based on its novel ... presented at a major medical meeting showed that ... anxiolytic-like activity with no signs of the CNS-related ... NMDA receptor(1). The studies also showed that ...
(Date:12/16/2009)... NEW YORK, Dec. 16 Keryx ... today the initiation of a Phase 3 ... Company,s PI3K/Akt pathway inhibitor, in relapsed / ... entitled, "A Phase 3 Randomized Study to ... Added to the Combination of Bortezomib (Velcade®) ...
Breaking Medicine Technology:MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 2MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 3MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 4Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 2Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 3Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 4Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 5Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 6Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 2Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 3Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 4Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 5Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 6Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 7New Directions in Angioedema 3A A Focus on Etiologies and Clinical Approach 48496 1New Directions in Angioedema 3A A Focus on Etiologies and Clinical Approach 48496 2Parents key in new measure to evaluate language in children with autism 48494 1Parents key in new measure to evaluate language in children with autism 48494 2Parents key in new measure to evaluate language in children with autism 48494 3Pre pregnancy depressed mood may heighten risk for premature birth 8792 1Pre pregnancy depressed mood may heighten risk for premature birth 8792 2Pre pregnancy depressed mood may heighten risk for premature birth 8792 3
... ARIAD,Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that clinical,investigators ... and,1b clinical data from ongoing trials of the ... of the American Society,of Clinical Oncology (ASCO) in ... from the Phase 2 trial of single-agent,AP23573 in ...
... /PRNewswire-FirstCall/ -- Iomai,Corporation today announced that it will ... patch-based needle-free influenza vaccine,before the markets open tomorrow. ... at 8:30 a.m. Eastern Time tomorrow to discuss,the ... the live conference call Friday, May 25, 2007 ...
Other Medicine Technology:Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 2Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 3Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 4Iomai to Announce Results From Phase 1 Influenza Trial and Host,Webcast Tomorrow 2
(Date:12/16/2009)... Quantros, Inc., a leading provider of safety and ... healthcare industry, announces the creation of a new ... industry veteran Michael Tulloch, MBA, as Director of ... company,s new Marlborough, MA office. ,, "The expansion ... Tulloch. "Quantros has been developing software for the ...
(Date:12/16/2009)... What happens when the families of sick and dying ... or for them? How do pediatricians respond to such ... religion and spirituality help some patients and families cope ... is almost always the families and patients who raise ... In the current issue of Southern Medical Journal ...
(Date:12/16/2009)... Dec. 16 Tyco International Ltd. (NYSE: ... of Michael E. Daniels for election to the ... General Meeting on March 10, 2010. ,, ... Global Technology Services group of International Business Machines ... for IBM,s Global Services business operations consisting of ...
(Date:12/16/2009)... While many of the,pharma companies are struggling ... and inmarket drugs, MarketsandMarkets on the other ... players. These pharma,forecasting solutions are designed for ... phase,III. These have a substantial impact on ... strategy, manufacturing planning, sales force,promotion, and planning. ...
(Date:12/16/2009)... donates time and money to help clothe children in need. ... ... Florida dry cleaner Dryclean USA Florida , along with Atlantic ... Hope to help clothe children in need by collecting funds ... will begin distributing cards, with delivery of their clean clothes, and ...
Breaking Medicine News(10 mins):Health News:Safety and Quality Software Developer Quantros, Inc. Launches Healthcare IT Consulting Division 2Health News:Prayer on the hospital floor 2Health News:Tyco International Files Preliminary Proxy Proposing Election of New Director 2Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 2Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 3Health News:Pay a Dollar, Dress a Child: Helping Struggling Families with Small Donations 2
... Internet - , , ANTHEM, Ariz., Dec. 29 ... of its new web site at http://www.mychoicedentist.com and ... Phoenix , Arizona, area is proceeding successfully. "Arizona is ... CEO. "We anticipate expanding this service to almost every major ...
... Now Worth Twenty-Five Thousand Dollars at www.MaxMuscle.com/max-formation/ , ... ... Sports Nutrition is rewarding $25,000 cash to the individual who can ... lean muscle and fitness in 2009., , , , ,Bring Yourself ...
... Critically ill patients frequently have uncertain prognoses, but ... prognostic uncertainty candidly, according to a new study ... Center. , "Our interviews revealed that caregivers ... and just the nature of life," said lead ...
... a timely reminder of the issues surrounding the binge ... people and alcohol, a team lead by Professor Christine ... funded by the Economic and Social Research Council (ESRC) ... Focusing on the role of marketing practices in shaping ...
... Team Sponsored by Land Rover, St. Regis Resort Aspen, National ... Land Rover America,s Polo Cup Team participated in the prestigious ... weekend filled with world class polo and camaraderie on and ... was comprised of John Gobin at 8 goals, (one of ...
... against troublesome complication, study finds , , FRIDAY, Dec. 26 ... before cardiac surgery may lower their chances of having ... on variables such as age and the complexity of ... this condition of confusion following heart surgery. The condition ...
Other Medicine News:Health News:Prime Companies Announces Launch of New Dental Web Site 2Health News:Max Muscle Sports Nutrition Offers $25,000 Reward For Your New Years Resolution 2Health News:Max Muscle Sports Nutrition Offers $25,000 Reward For Your New Years Resolution 3Health News:Max Muscle Sports Nutrition Offers $25,000 Reward For Your New Years Resolution 4Health News:Family members of critically ill patients want to discuss loved ones' uncertain prognoses 2Health News:T'is the season to be jolly? 2Health News:Land Rover America's Polo Cup Team Plays in USPA World Snow Polo Championships, Aspen, Colorado 2Health News:Land Rover America's Polo Cup Team Plays in USPA World Snow Polo Championships, Aspen, Colorado 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: